The app-based diagnostic and support approach with a focus on mental and somatic symptoms is intended to strengthen the resilience of premature born children and families and to identify risk and resilience factors.The overall objective of the study is to improve the post-inpatient care of families with premature born children. The procedure is evaluated by a two-arm design with an experimental group and a TAU group.
Age range
28 Weeks – 34 Weeks
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Questionnaire on satisfaction, feasibility, needs (FB-NB)
Timeframe: At month 4 (post-teatment, T1) and month 7 (follow-up, T2)
Parent Stress Inventory (EBI)
Timeframe: At baseline (before treatment, T0), at month 4 (post-teatment, T1) and month 7 (follow-up, T2).
Crying, Feeding and Sleeping Questionnaire (SFS)
Timeframe: At baseline (before treatment, T0), at month 4 (post-teatment, T1) and month 7 (follow-up, T2).
Annette Conzelmann, Prof.Dr.